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Abstract 
The aim of this study is to elucidate how the Isatidis Radix (板藍根 bǎn lán gēn) tonic, as an aqueous mixture of 
hundreds of compositions, interrupts the infection of influenza viruses to their host cells. The efficacy of the tonic was 
evaluated and expressed as cell proliferation rate and plaque reduction rate in Madin-Darby Canine Kidney (MDCK) 
cells, against 3 strains of influenza A and B viruses. This boiling water (at 100℃ ) extract of Isatidis Radix (RIE) 
showed antiviral activity against influenza virus A and B. The concentration for 50% inhibition of influenza virus A 
replication (IC50) in MDCK cell was 12.6 mg/mL with a therapeutic index >8. When cells were incubated with RIE 
prior to virus adsorption, the numbers of viable cell were at least doubled compared to the numbers of virus control, 
RIE incubation after virus adsorption and RIE incubation with virus prior to adsorption, in both influenza virus A and B. 
Moreover, much less virus particles were spotted by scanning electron microscope (SEM) in the RIE pre-treated cells 
than the cells without RIE treatment. These results indicate the antiviral activity of RIE is mainly attributed to its host 
cell protection effect but not actions on virus or post-virus-adsorption interruption. Cell, but not virus, is more likely to 
be the action target of RIE.
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Introduction
Isatidis Radix  (板藍根 bǎn lán gēn) is the dried 
roots of the plant Isatis indigotica Fort . or Isatis 
tinctoria L.  (Fam. Brassicaceae ), and a widely-used 
antiviral traditional Chinese medicine. As an officially 
approved medicinal material (Chinese Pharmacopoeia 
Commission, 2005), Isatidis Radix  and its decoction 
(RIE) have been employed as a major herbal tonic 
in prevention and treatment against a wide range of 
viral infections, including seasonal flu and the deadly 
Severe Acute Respiratory Syndrome (SARS) (LinHWDO 
2005). Regardless of the different subtypes of viruses 
and their constant mutations, RIE was found to be 
clinically effective against infections caused by various 
subtypes and strains of influenza viruses. The antiviral 
mechanism of RIE remains unclear, with no indication 
of the target of the antiviral action of RIE, an essential 
prerequisite to elucidation of the mechanism. There is, 
as yet, no explanation of the wide spectrum of activity 
against all strains of the influenza virus.
In our previous studies (ChenHWDO 2006), RIE was 
demonstrated to prevent the influenza virus induced 
hemaegglutination, and remarkably change the surface 
This is an open access article under the CC BY-NC-ND license.
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charge of erythrocytes, measuring with capillary 
electrophoresis of erythrocytes (LuHWDO 2003). It 
implied that the anti-hemaegglutination activity of RIE 
might rely on the action upon erythrocytes rather than 
virus. 
In this paper we sought to determined the antiviral 
activity of RIE using Madin-Darby Canine Kidney 
(MDCK) cells and 3 strains of influenza virus A and B. 
Attempts were made to identify either cell or virus the 
target of RIE’s action, by comparison of the antiviral 
efficacy of RIE interference introduced before or after 
virus adsorption on MDCK cells. 
Materials and Methods
Preparation of the aqueous extracts of Isatidis Radix 
(RIE)
Fresh roots of Isatis indigotica Fort. were harvested 
and sun-dried in Fuyang City, Anhui Province, P.R. 
China. Roots were dried at 20~25℃ (day), 5~10℃ 
(night), for 2 ~ 4 weeks. The yield of sun drying was 
1 kg sun-dried roots from 2.5 kg fresh roots. The 
preparation of aqueous extracts of Isatidis Radix (RIE) 
was following the instructions of China Pharmacopeia 
(Chinese Pharmacopoeia Commission, 2005). 1400 g 
sun-dried roots were extracted twice with 3 L boiling 
water at 100℃ , for 2 h and 1 h, respectively. The 
solution was filtered and vacuum concentrated at 50℃ 
until the relative density reached 1.20. After the stock 
was precipitated by 60% ethanol at 4℃ , the precipitates 
were removed, then the suspension was vacuum 
concentrated at 50℃  to produce the RIE as brown 
powder.
Cells and virus 
Continuous MDCK cells (China Center for Type 
Culture Collection) were maintained in DMEM 
(Invitrogen Corporation) with 10% calf serum (GIBCO), 
penicillin G (100 mg/L), streptomycin (80 mg/L), and 
sodium bicarbonate (3.7 g/L).
Influenza strains A/Beijing/95-262(H1N1/C2E3, 1:640 
8/2/99) and B/Shanghai/93-1(C3C2, 1:320 9/2/99) were 
purchased from the National Influenza Center of China. 
Influenza A virus FM1 (H1N1, mouse-adapted strain) 
was generously provided by Fujian Centre of Disease 
Control (Fuzhou, Fujian, P.R.China). All viruses were 
propagated in the allantoic cavity of 11-day-old chick 
embryos at 33℃ for 48 h. Isolated virus stocks were 
stored in aliquots of phosphate buffered saline at -80℃ . 
Determination of Cytotoxicity 
Cytotoxic effects of the decoction (1-100 mg/mL) 
were determined by a dye uptake assay with crystal 
violet (0.03%, w/v) using MDCK cells (Schmidtke 
et al . ,  2001). Six duplicates were use for each 
concentration. The cell viability was presented as cell 
survival rate, which is calculated with Equation 1 . 
Cell survival rate 
= (mean O.D. sample / mean O.D. control) × 100%  (TXDWLRQ
Determination of antiviral activities upon 3 strains of 
influenza virus A and B
Following the established protocol (Levi HWDO
1995), MDCK cell monolayers (105 cells/well) in 
96-well plates were washed with PBS and infected 
with 50 PFU (plaque forming units) of influenza virus 
A/Beijing/95-262, FM1, B/Shanghai/93-1, for 60 min 
at 33℃  in the presence or absence of RIE. The infected 
cells were then incubated with 200 µL maintenance 
medium containing RIE (1-100 mg/mL) for 3 d. 
Antiviral activity was determined using MTT assay 
(van de Loosdrecht et al ., 1994) and plaque reduction 
assay (Gaush and Smith, 1968; Burleson HWDO 1992). 
Cell control with/without the extracts and virus controls 
were included. Antiviral activity was calculated as 
a percentage of protection from virus-induced cell 
proliferation inhibition and cell destruction, in relation 
to infected cell without RIE and mock-infected control 
(Equation 2&3). The concentration for 50% inhibition 
of virus (IC50) were calculated by Reed-Muench method 
(Reed and Muench, 1938).
Cells protection rate (%)
=(O.D.VR − O.D.V)/(O.D.R − O.D.V)×100 Equation 2
(O.D.VR = infected cell with RIE; O.D.V 
= infected cell without RIE; O.D.R = cell with RIE)
Plaque inhibition rate (%) 
= [(control -sample)/ control] ×100  Equation 3
Determination of antiviral activities on different 
stages of viral replication cycle
A single concentration of RIE (50 mg/mL) was 
introduced to influenza virus A/Beijing/95-262, A FM1 
and B/Shanghai/93-1, in three different modes: 1) 
cell protecting mode: cells were pre-treated with RIE 
at 33℃ for 180 min before virus adsorption; 2) cell 
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repairing mode: after virus adsorption, infected cells 
were incubated with RIE at 33℃  for 180 min, and were 
washed twice with PBS; 3) virus diminishing mode: 
virus was pre-incubated with RIE at 33℃ for 180 min 
before being introduced to cells. Antiviral activity of 
different mode was determined with MTT assay and 
presented as cell viability, calculated with Equation 1 . 
Scanning Electron Microscopy (SEM)
Scanning electron microscope was used to directly 
observe the morphological cytopathogenicity induced by 
50 PFU influenza A FM1. MDCK cells were grown to 
confluence on polyethyleneimine-coated cover slips (10 
mm diameter) in 24-well plastic tissue culture plates (16 
mm well diameter). RIE (15 mg/mL) was administrated 
to cells in 3 modes described above. In addition, for 
investigating RIE’s effects on virus adsorption, the 
cells with/without RIE pre-treatment were incubated 
with viruses at 4℃ for 1 h to allow the occurrence of 
virus attachment to cell membrane. The cells were 
then prepared for SEM observation with an established 
protocol (Watanabe et al., 2004). After being washed 
with PBS buffer for 3 times, the cells were fixed with 
2.5% glutaraldehyde-2.0% paraformaldehyde in 0.1 M 
cacodylate buffer (pH 7.4) for 1 h at room temperature, 
and post-fixed with 1% OsO4 in the same buffer for 45 
min, followed by thoroughly washing and dehydrating 
in ethanol, being treated with isoamyl acetate and dried 
to a critical point with HCP-2. The cells were mounted 
on stubs, coated with gold and observed with a scanning 
electron microscope (JSM5310/LV, JEOL).
Results and Discussion
Cytotoxicity of RIE
Cell survival rates decreased significantly when the 
concentration of RIE risen from 40 to 100 mg/mL, 
whereas no significant difference was observed at 
concentrations lower than 10 mg/mL. The lowest cell 
survival rate of all assayed RIE concentrations was 
53% (at 100 mg/mL), indicating the 50% cytotoxic 
concentration (CC50) of RIE on MDCK cells is 
estimative >100 mg/mL.
Antiviral activity against influenza virus A and B
As shown in Table 1, two strains of influenza virus 
A appeared to be more susceptive to RIE than did the 
influenza virus B. IC50 of RIE on virus A was under 
20 mg/mL, whereas it was around 50 mg/mL on virus 
B. The therapeutic index (TI) of RIE was >8 on virus 
A while only >2 on virus B. The different impacts of 
RIE on influenza A and B viruses warrant further study. 
Moreover, in this test, the incubation of 100 mg/mL 
RIE with cells and influenza A virus together raise the 
cells survival rate up to 91%, and the plaque inhibition 
rate up to 96%. The survival rate here is higher than its 
counterpart in the cytotoxicity test (53%) in the presence 
of high concentration of RIE. It is because the impacts 
of RIE treatment on the viability of normal cells have 
been subtracted for the evaluation of RIE’s influence 
on the viral infection.  This result indicates that RIE 
efficiently inhibited viral infection even at its cytotoxic 
concentrations. 
Moreover, the IC50 of RIE ranged from 12.6 to 
50.1 mg/mL, which seems too high to be an efficient 
antiviral agent. However, two factors have to be taken 
into account. Firstly, during IC50 evaluation, RIE was 
introduced to cells with the virus together instead 
of prior to virus incubation, which might provide an 
undervalued IC50. Secondly, as a mixture, RIE contains 
hundreds of compositions, of which a small proportion 
would be responsible for the efficacy. For example, only 
one fifth of total protein of Isatidis Radix  is aqueous 
soluble. Nagai et al . have reported the anti-influenza 
virus activity of a glycoprotein from roots of Isatis 
tinctoria L.  (Nagai et al., 1998). Therefore, aqueous 
soluble proteins may possibly contribute to the antiviral 
effects of Isatidis Radix. Purification of the effective 
components of RIE is in progress.
Antiviral activities on different stages of viral 
replication cycle
As enveloped viruses, the infectious cycle of 
influenza virus primarily involves four steps: binding 
to a receptor on the membrane, membrane fusion or 
entry, replication and assembly, and budding (Whittaker 
and Digard, 2006). Together these provide several 
opportunities for antiviral agents to inhibit the viral 
infectious cycle, by acting on either the host cells or 
Table 1. Antiviral activity of extract of Isatidis Radix against 3 strains 
of influenza virus A and B using MTT assay and plaque reduction 
assay.
a   Therapeutic Index (TI) was calculated with equation TI=(CC50/IC50), 
CC50=100 mg/mL. Because the real CC50 was estimated to be higher 
than 100 mg/mL, TI values should be higher than the results of 
calculation.
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the viruses. For example, some antibodies inhibit the 
attachment of viruses to cells  (Reading and Dimmock, 
2007). Peptidyl chloroalkyl ketone inhibitors prevent 
the fusion event by inhibiting cleavage of the precursor 
of HA (Tashiro and Rott, 1996); the approved drugs 
amantadine and rimantadine stop viral particles 
from releasing into the cytoplasm by the inhibition 
of viral particles uncoating (Pinto and Lamb, 2007); 
neuraminidase inhibitor, i.e. Tamiflu, prevents the 
budding of progeny virus from the cell membrane 
(Moscona, 2005).
Prior to the antiviral mechanism of RIE and its 
components are illuminated, the action targets of 
RIE have to be firstly narrowed down to either cells 
or viruses. The anti-hemaegglutination activity of 
RIE attributed to the action upon erythrocytes rather 
than virus (Chen et al., 2006). Likewise, another 
t radi t ional  Chinese herbal  tonic,  Momordicae 
Charantiae Fructus (苦瓜 kǔ guā) extracts, has shown 
its cytoprotective effects on pancreatic islet cells (Ke 
et al., 2011). Therefore, RIE is hypothesised to conduct 
cytoprotective effects on virus host cells, i.e. MDCK 
cells in this study. 
It is important to note that the efficacy of RIE is 
corresponding to with which stage of virus infection RIE 
interfered. In contrast with virus control, only the “cell 
protecting mode” achieved a significant improvement 
(P < 0.01) on cell survival rates among the three modes, 
as shown in Table 2, whereas neither “cell repairing 
mode” nor “virus diminishing mode” did the same. 
Corresponding with cell survival rates, the virus titres in 
suspensions measured with the hemaegglutination assay 
only decreased in the “cell protecting mode” of cells.
Consistent with the cell viability tests above, no 
cytopathogenic effect (CPE) of MDCK cells was 
observed with SEM in the “cell protecting mode”, in 
which cells were incubated with RIE prior to virus 
infection. Much fewer virus particles appeared on the 
surface of RIE pre-treated cells (Figure 1a) than the 
cells without RIE treatment (Figure 1b). To ensure the 
proposed inhibitory effects, the concentration of RIE 
used in the SEM study was 15 mg/mL, a middle value 
of the effective concentrations against influenza virus A. 
Two assumptions are drawn from the results. Firstly, 
as RIE failed to prevent viral infection by direct actions 
on viruses and neutralising them, RIE is assumed 
to act on MDCK cells rather than influenza viruses. 
Secondly, RIE can bind to cell plasma membrane or 
enter cell plasma and affect the early events of viral 
Table 2. Effects of extract of Isatidis Radix (RIE) on viruses, host cells 
and early steps of infectious cycle of influenza virus A and B using 
MTT assay.
The extract of Isatidis Radix (RIE, 50 mg/mL) was used in all the 
groups. The proliferation rate of the normal Madin-Darby Canine 
Kidney cell control was defined as 100%. RIE showed protective 
effects against virus only in “cell protecting mode”, but no effect in 
“cell repairing mode” and “virus diminishing mode”. (n≥4) **, P < 
0.01; others, P > 0.05.
Figure 1.  Scanning electron micrographs of Madin-Darby Canine 
Kidney cells inoculated with 50 PFU influenza A FM1 (H1N1, mouse-
adapted) virus, with/without extract of Isatidis Radix (RIE, 15 mg/mL) 
pre-treatment. 
(a)  “Protecting mode: with RIE pre-treatment”, cells were incubated 
with viruses at 4℃ , magnified ×5000;
(b)  “‘Control: without RIE pre-treatment”, cells were incubated with 
viruses at 4℃ , magnified ×5000;  
Cells were fixed with Karnovsky’s fixative, post-fixed with 1% 
OsO4 for 45 min, dehydrated in ethanol, treated with isoamyl 
acetate and dried to a critical point with HCP-2. The cells were 
mounted on stubs, coated with gold and observed with a scanning 
electron microscope (JSM5310/LV, JEOL).
Arrows: virus particles bound to the microvilli and other parts of 
plasma membrane.
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infection, i.e. binding and fusion of membrane, and 
thereafter uncoating of virus particles in cytoplasm. 
These assumptions are based on following observations. 
As any free RIE was thoroughly washed off after 
incubation with cells in all three groups, only those RIE 
who bound to the cell plasma membrane or internalised 
into the cell plasma would contribute to the rise of cell 
survival rates. Furthermore, because of the stronger 
effects of “protecting mode” than “repairing mode”, it is 
crucial for RIE to participate cell-virus interaction in an 
early stage, particular prior to the presence of viruses. 
Hence, the inhibitory effects of RIE on viral infection 
may be confined to the adsorption and fusion stage of 
infection. This assumption is supported by SEM studies 
assayed, in which very few virus particles were seen to 
bind to the RIE pre-treated cells. 
Conclusions
The present study indicates that the decoction of 
Isatidis Radix  inhibits the attachment of influenza 
virus to MDCK cells by binding to and subsequently 
modifying the cell plasma membrane. This is the 
first time the target of an antiviral traditional Chinese 
medicine has been located in the host cells. Potentially, 
a new family of antiviral agents may be developed 
from RIE, using its unique antiviral approach of 
preventing the virus from attaching to its host cell 
plasma membrane. Furthermore, as it targets on an 
universal substance, the cell plasma membrane, this 
approach may function upon a wide range of enveloped 
viruses, regardless of their families, types, strains or 
year of epidemic. More beautifully, due to the high 
conservativeness of membrane lipids, this approach 
is expected to have a low risk of developing virus 
resistance. Further studies are requested to purify the 
effective components of RIE and identify their binding 
sites on cell membrane.  
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